Related Experiment Video
Updated: May 12, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Baicalein suppresses Coxsackievirus B3 replication by inhibiting caspase-1 and viral protease 2A
Yanyan Dong1, Enze Shao1, Siwei Li1
1Department of Cell Biology, Harbin Medical University, Harbin 150081, China.
Insights
Baicalein, a natural compound, effectively combats coxsackievirus B3 (CVB3) infection, reducing viral load and alleviating myocarditis. This flavonoid shows promise as a potential treatment for enterovirus-induced heart inflammation.
Area of Science:
- Cardiology
- Virology
- Pharmacology
Background:
- Myocarditis, an inflammation of the heart muscle, is a leading cause of dilated cardiomyopathy.
- Group B coxsackievirus (CVB) is a primary pathogen responsible for viral myocarditis, particularly in young individuals.
- The absence of vaccines necessitates the development of effective antiviral therapies against CVB.
Purpose of the Study:
- To investigate the antiviral efficacy of baicalein, a flavonoid derived from Scutellaria baicaleinsis.
- To determine baicalein's potential as a therapeutic agent for CVB-induced myocarditis.
Main Methods:
- Assessing the impact of baicalein on CVB3-infected cells, measuring cytopathic effects and cell viability.
- Quantifying viral protein, RNA, and particle levels following baicalein treatment.
- Evaluating baicalein's effect on viral replication in the myocardium and myocarditis severity in vivo.
- Investigating the molecular mechanisms, including inhibition of caspase-1 and viral protease 2A.
Main Results:
- Baicalein significantly reduced cytopathic effects and enhanced cell viability in CVB3-infected cells.
- Treatment with baicalein led to substantial decreases in viral protein 3D, viral RNA, and viral particle production.
- Baicalein demonstrated inhibitory effects in the early stages of CVB3 infection, suppressed myocardial viral replication, and alleviated myocarditis.
- The antiviral action of baicalein was linked to the inhibition of caspase-1 and viral protease 2A activity.
Conclusions:
- Baicalein exhibits significant antiviral activity against coxsackievirus B3 (CVB3) infection.
- Baicalein effectively suppresses viral replication and alleviates CVB3-induced myocarditis.
- Baicalein represents a potential therapeutic candidate for myocarditis caused by enterovirus infections.
Abstract:
Myocarditis is an inflammatory disease of the cardiac muscle and one of the primary causes of dilated cardiomyopathy. Group B coxsackievirus (CVB) is one of the leading causative pathogens of viral myocarditis, which primarily affects children and young adults. Due to the lack of vaccines, the development of antiviral medicines is crucial to controlling CVB infection and the progression of myocarditis. In this study, we investigated the antiviral effect of baicalein, a flavonoid extracted from Scutellaria baicaleinsis. Our results demonstrated that baicalein treatment significantly reduced cytopathic effect and increased cell viability in CVB3-infected cells. In addition, significant reductions in viral protein 3D, viral RNA, and viral particles were observed in CVB3-infected cells treated with baicalein. We found that baicalein exerted its inhibitory effect in the early stages of CVB3 infection. Baicalein also suppressed viral replication in the myocardium and effectively alleviated myocarditis induced by CVB3 infection. Our study revealed that baicalein exerts its antiviral effect by inhibiting the activity of caspase-1 and viral protease 2A. Taken together, our findings demonstrate that baicalein has antiviral activity against CVB3 infection and may serve as a potential therapeutic option for the myocarditis caused by enterovirus infection.
More Related Videos
Related Concept Videos
Caspases
Inhibition of CDK Activity
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Viral Protein Synthesis

